"Aware Many People Are Waiting...": WHO On Covaxin Approval
NDTV
WHO's chief scientist Soumya Swaminathan said on Sunday WHO's technical advisory group will meet on October 26 to consider the listing for Covaxin.
The World Health Organization said on Monday it expects Bharat Biotech to provide more information on its COVID-19 vaccine in a further setback to the company's hopes of getting an emergency-use listing for the shot. We are aware that many people are waiting for WHO's recommendation for Covaxin to be included in the #COVID19 Emergency Use Listing, but we cannot cut corners - before recommending a product for emergency use, we must evaluate it thoroughly to make sure it is safe and effective. pic.twitter.com/GDx8GAc1KU
Without WHO's nod the two-dose Covaxin is unlikely to be accepted as a valid COVID-19 vaccine around the world. Bharat Biotech has been pursuing a WHO emergency-use listing for several months, having submitted data on a rolling basis since July.
"We are aware that many people are waiting for WHO's recommendation for (Bharat Biotech's) Covaxin to be included in the #COVID19 Emergency Use Listing, but we cannot cut corners," WHO said on Twitter.
